Real-world studies in COPD: What does the evidence say?

Dr Richard Russell is joined by Professor Antonio Anzueto in this episode of the Medical Insider COPD podcast to talk about real-world evidence and the gaps it can fill in the world of COPD research. Listen as they compare the finding from randomised controlled trials with real-world data and discuss how guidelines can be implemented in clinical practice. 1-3 Dr Russell will also highlight a new and exciting publication on the role of blood eosinophils in the development of obstructive lung disease, 4 before delving into this week’s social media hot topic of COPD fatigue. Make sure to subscribe so you don’t miss out!

1. Quint JK, et al. Adv Ther 2021;38:2249–2270; 2. Global Initiative for Chronic Obstructive Lung Disease. Updated 2022. Available here. Last accessed: November 2022; 3. Halpin DMG, et al. Respir Res 2016;17:120; 4. Park HY, et al. Eur Respir J 2021;58:2003823.

Disclosures Dr Antonio Anzueto Dr Anzueto reports consultancy and advisory board membership fees from AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Novartis and Teva Pharma; he also reports research grants from GlaxoSmithKline. Dr Anzueto is a member of the ATS/ERS Task Force on COPD, is a member of the GOLD Scientific Committee and is a member of the Infectious Diseases Society of America/ATS Community-Acquired Pneumonia Guidelines Committee.

Bios:

Dr Antonio Anzueto Antonio R. Anzueto, MD, is a Professor of Pulmonary/Critical Care in the department of Medicine at the University of Texas Health, San Antonio. He is Chief in the Pulmonary Section, Audie L. Murphy Memorial Veterans’ Hospital Division in San Antonio, Texas, where he also serves as Medical Director of the Respiratory Therapy Department and Medical Director of the Pulmonary Function Laboratory. Dr Anzueto currently serves on the editorial board of the American Journal of Respiratory and Critical Care Medicine, the American College of Chest Physicians (CHEST) journal, the COPD journal and the Respiratory Research journal. He is affiliated with several professional organisations, including the European Respiratory Society (ERS), the American Thoracic Society (ATS) and Global Obstructive Lung Disease (GOLD) initiative.

 

This series of podcasts are intended for healthcare professionals only.

The Medical Insider COPD podcast series discusses hot topics in the world of COPD with those who know it best, aiming to spread information, debunk myths and improve the lives of patients. The Editorial Board of the Medical Insider COPD podcast is comprised of Professor James Chalmers, the British Lung Foundation Chair of Respiratory Research at the University of Dundee (UK), Professor Michael Dreher, the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany), and the host and moderator, Dr Richard Russell, a Consultant Chest Physician at Lymington New Forest Hospital (UK), a Senior Clinical Researcher at the University of Oxford (UK) and the founding editor of the International Journal of COPD. These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.

Copyright © 2021, Boehringer Ingelheim Group of Companies. All rights reserved.